SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Willow Biosciences Inc. (WLLW.TO) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 22/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — WLLW.TO
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.05
Book Value / Share$0.00
Revenue / Share$0.03
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-9.72 |
$0.00 |
$-1.31M |
- |
| 2016 |
$-8.37 |
$0.00 |
$-2.33M |
- |
| 2017 |
$-2.58 |
$0.00 |
$-1.86M |
- |
| 2018 |
$-0.75 |
$16.91K |
$-1.64M |
-9723.7% |
| 2019 |
$-0.62 |
$4.58K |
$-44.57M |
-972220.5% |
| 2020 |
$-0.41 |
$10K |
$-33.99M |
-339860% |
| 2021 |
$-0.05 |
$133K |
$-6.17M |
-4636.8% |
| 2022 |
$-0.12 |
$821K |
$-14.81M |
-1804.4% |
| 2023 |
$-0.10 |
$1.17M |
$-13.03M |
-1111.7% |
| 2024 |
$-0.05 |
$4.66M |
$-6.19M |
-132.8% |
